scholarly journals Clinical Value of the Total White Blood Cell Count and Temperature in the Evaluation of Patients with Suspected Appendicitis

2004 ◽  
Vol 11 (10) ◽  
pp. 1021-1027 ◽  
Author(s):  
T. Cardall
Keyword(s):  
Blood Cell ◽  
Cell Count ◽  
White Blood Cell Count ◽  
White Blood Cell ◽  
Total White Blood Cell ◽  
Blood Cell Count ◽  
Clinical Value ◽  
Suspected Appendicitis

scholarly journals Analysis of Using the Total White Blood Cell Count to Define Severe New Onset Ulcerative Colitis in Children

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
David R. Mack ◽  
Bradley Saul ◽  
Brendan Boyle ◽  
Anne Griffiths ◽  
Cary Sauer ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Blood Cell ◽  
Cell Count ◽  
White Blood Cell Count ◽  
White Blood Cell ◽  
Total White Blood Cell ◽  
Blood Cell Count ◽  
New Onset

scholarly journals EFFECTS OF PROBIOTIC SACCHAROMYCES BOULARDII AND CO-TRIMOXAZOLE ON SOME HAEMATOLOGICAL PARAMETERS IN ADULT WISTAR RATS

2021 ◽  
Vol 2 (2) ◽  
pp. 55-62
Author(s):  
P. A. Obazelu ◽  
I. A. Aruomaren ◽  
C. C. Nwangwu
Keyword(s):  
Body Weight ◽  
Blood Cell ◽  
Cell Count ◽  
Cell Volume ◽  
White Blood Cell Count ◽  
White Blood Cell ◽  
Packed Cell Volume ◽  
Saccharomyces Boulardii ◽  
Total White Blood Cell ◽  
Blood Cell Count

Saccharomyces boulardii is a probiotic yeast used as a nutritional supplement. Co-trimoxazole, is a broad-spectrum antimicrobial agent used in the prophylaxis and treatment of infections.The goal of this study was to evaluate the individual and interactive effects of probiotic Saccharomyces boulardii and co-trimoxazole on some haematological parameters in albino rats. Thirty (30) albino Wistar rats weighing 150-200g were divided into five groups; Basal, A, B, C, and D, with six animals in each group. Group A (control) was given a normal rat pellet (standardized feed) and clean water (pH 6.5- 8.5). Group B was administered 5.5mg/kg body weight of the commercial probiotics (Saccharomyces boulardii). Group C was administered 4.4mg/kg body weight of co-trimoxazole. Group D was administered 5.5mg/kg body weight of the commercial probiotics and 4.4mg/kg body weight of co-trimoxazole. All administrations were done using a gavage tube for 15 days. Blood samples were collected for analysis on days 0, 5 and 15. The results showed that Saccharomyces boulardii caused a significant increase (P<0.05) in total white blood cell count and packed cell volume of the treated groups at day 5. On day 15, the total white blood cell count (10.67±0.66), packed cell volume (43.23±0.47), platelet count (932±38.89) and mean platelet volume (8.53±0.38) showed a significant increase (P<0.05) in the probiotic group. The co-trimoxazole group showed a significant reduction (P<0.05) in the packed cell volume and total white blood cell count. This study shows that Saccharomyces boulardii has a positive effect on the haematological profile of the test animals.

scholarly journals Total white blood cell count, liver enzymes, and metabolic syndrome in schizophrenia

2016 ◽  
Vol 46 ◽  
pp. 259-264 ◽  
Author(s):  
Görkem KARAKAŞ UĞURLU ◽  
Semra ULUSOY KAYMAK ◽  
Mustafa UĞURLU ◽  
Sibel ÖRSEL ◽  
Ali ÇAYKÖYLÜ
Keyword(s):  
Metabolic Syndrome ◽  
Blood Cell ◽  
Cell Count ◽  
White Blood Cell Count ◽  
White Blood Cell ◽  
Liver Enzymes ◽  
Total White Blood Cell ◽  
Blood Cell Count

scholarly journals The Dynamic Changes of White Blood Cell Count and Lymphocyte Count and Compare their Levels in the Early Stage of Covid-19

2021 ◽  
Vol 3 (1) ◽  
pp. 8-13
Author(s):  
Ling Wang
Keyword(s):  
Infectious Disease ◽  
Blood Cell ◽  
Cell Count ◽  
White Blood Cell Count ◽  
White Blood Cell ◽  
Normal Level ◽  
Early Stage ◽  
Blood Cell Count ◽  
Clinical Value ◽  
Dynamic Changes

COVID-19 is a new infectious disease, which needs to explore the clinical value of white blood cell count and lymphocyte to provide help for diagnosis and treatment.COVID-19 cases were Selected that admitted to 2 hospitals in Guizhou, China. WBC and LYM in the 1st day, in the 4th day and in the 7th day after onset were collected. There were not any differences in The WBC and LYM in the 4th day and the 7th day between the two groups.WBC and LYM in the 1st day in the moderate group were lesser than in the mild group. WBC and LYM were no dynamic changes in the mild group. In moderate group, WBC and LYM in the 1st day were lesser than in the 4th day. The levels in the 4th day and the 7th day were no differences. The conclusion was In the early stage of COVID-19, the WBC and LYM in moderate patients were significantly decreased within 4 days after onset, and could be restored to normal level after 4-7 days. However, no dynamic changes were observed in mild patients within 7 days.

Sign in / Sign up

Export Citation Format

Share Document